ImmXcyte

N/A

Report date: 2025/01/26 19:07:12

Base Information

Drug NameImmXcyte
Drug Alias NameHp91 adjuvant (Batu Biologics)Hp91 adjuvant (University of California San Diego)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionToll like receptor 4 agonistsHigh Mobility Group Protein B1 modulators
TargetsHigh Mobility Group Protein B1Toll like receptor 4
Therapy Area/IndicationsVaccinationMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesBatu Biologics
Inactive CompaniesUniversity Of California San Diego
Active IndicationsMelanoma
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A